GHU Logo
The Great Heights University Library
Academic discovery, digital access, and research support

Cancer and Metastasis Reviews (Record no. 4452)

MARC details
000 -LEADER
fixed length control field 03508nas a22003495i 4500
001 - CONTROL NUMBER
control field 1573-7233
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20260610082533.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 150723s||||||||xxuuu poo|||||| b|EN |d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1573-7233
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/10555.1573-7233
Source of number or code doi
210 10 - ABBREVIATED TITLE
Abbreviated title Cancer Metastasis Rev
245 10 - TITLE STATEMENT
Title Cancer and Metastasis Reviews
Medium [electronic resource] /
Statement of responsibility, etc. edited by Erica Golemis, Kenneth V. Honn, Avraham Raz.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture New York :
Name of producer, publisher, distributor, manufacturer Springer US :
-- Imprint: Springer.
300 ## - online resource
Other physical details online resource.
520 ## - SUMMARY, ETC.
Summary, etc. Aims and Scope Research advances over the past decades have in many cases transformed advanced cancer from a lethal diagnosis to a manageable chronic condition; in some cases, advanced cancers can even be cured. These advances have been driven by fundamental research into the mechanisms which malignant transformation subverts the machinery of the cancer cell and impacts the tumor microenvironment. Translational work guided by these basic discoveries has led to better strategies for cancer prevention, guided the creation of new targeted cancer therapies, and spurred the performance of clinical trials to assess efficacy of new therapeutic modalities. The volume of publications on these topics is vast, and increasing, and the need for thoughtful analysis and synopsis is greater than ever. The goal of Cancer & Metastasis Reviews is to highlight recent significant advances in basic, translational, and clinical research, emphasizing studies that have high impact for control of cancer, or have outstanding potential in this regard. Topics that will be considered include: Function of oncogenes and tumor suppressors Regulation of cell death in cancer Control of cell cycle and DNA repair in cancer Inflammation and immune system defects related to carcinogenesis Impact of the microbiome on carcinogenesis and therapeutic response Changes in cell metabolism linked to transformation Genetic and epigenetic changes during tumor formation, progression, metastasis, and response to treatment Tumor microenvironment, pre-metastatic and metastatic niches, and tumor dormancy Aging and cancer Development of molecularly targeted cancer therapies, including cellular therapies and immunotherapies, and clinical trials of such agents Biological and molecular factors related to cancer risk, cancer prevention, and cancer interception Systems biology and computational biology technologies for identification and characterization of cancer targets Technologies for early detection of new or recurrent tumors, and for monitoring response to treatment Predictive and prognostic biomarkers for cancer therapy. Cancer Disparities Founding Editors Isaiah J. Fidler†, PhD Garth L. Nicolson(Emeritus), PhD George Poste, PhD, Arizona State University, Scottsdale, Arizona, USA .
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oncology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Medicine—Research.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biology—Research.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer Biology.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oncology.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biomedical Research.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Golemis, Erica.
Relator term editor.
Relationship edt
-- http://id.loc.gov/vocabulary/relators/edt
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Honn, Kenneth V.
Relator term editor.
Relationship edt
-- http://id.loc.gov/vocabulary/relators/edt
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Raz, Avraham.
Relator term editor.
Relationship edt
-- http://id.loc.gov/vocabulary/relators/edt
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed version:
International Standard Serial Number 0167-7659
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/10555.1573-7233">https://doi.org/10.1007/10555.1573-7233</a>
Public note Hybrid

No items available.